Global X SuperDividend ETF (SDIV) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- Broad Market / FactorSector
- $26.3452W High
- $22.9052W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track Global X SuperDividend ETF (SDIV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Global X SuperDividend ETF has traded between a low of $22.9 and a high of $26.34, highlighting its annual price range. Buy and sell Global X SuperDividend ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Global X SuperDividend ETF
SDIV is an ETF that invests in 100 of the highest dividend-yielding equity securities in the world. The fund seeks to provide a high level of income to investors by selecting companies from both developed and emerging markets that have historically provided high dividend yields. By diversifying globally, SDIV aims to mitigate risks associated with focusing on a single country, while offering monthly distributions to its shareholders.
Most Recent News
Babcock & Wilcox rated STRONG BUY on growth from data center power solutions and major contracts.
Babcock & Wilcox (BW) is rated a strong buy due to its strategic position in providing fast, modular power solutions for data centers amid rising demand and grid limitations. The company secured a $2.4 billion Base Electron contract and has a $14 bil...
Great Western Mining starts drilling at Nevada's Defender Tungsten Project aiming for first resource estimate by 2026 end.
Great Western Mining Corporation has launched a fully funded drilling program at its Defender Tungsten Project in Nevada, targeting a maiden mineral resource estimate by the end of 2026. The program involves drilling at least 7,000 feet across up to ...
First commercial kidney transplant in Australia using Hansa's Idefirix treatment marks a key milestone.
Hansa Biopharma announced the first commercial living donor kidney transplant in Australia using Idefirix (imlifidase), a treatment that helps highly sensitized patients overcome immune barriers to transplantation. This milestone is significant as it...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.